Cargando…
Receptor Interacting Protein Kinases 1/3: The Potential Therapeutic Target for Cardiovascular Inflammatory Diseases
The receptor interacting protein kinases 1/3 (RIPK1/3) have emerged as the key mediators in cell death pathways and inflammatory signaling, whose ubiquitination, phosphorylation, and inhibition could regulate the necroptosis and apoptosis effectually. Recently, more and more studies show great inter...
Autores principales: | Leng, Yiming, Zhang, Ying, Li, Xinyu, Wang, Zeyu, Zhuang, Quan, Lu, Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637748/ https://www.ncbi.nlm.nih.gov/pubmed/34867386 http://dx.doi.org/10.3389/fphar.2021.762334 |
Ejemplares similares
-
G Protein-Coupled Receptor Kinase 2 (GRK2) as a Potential Therapeutic Target in Cardiovascular and Metabolic Diseases
por: Murga, Cristina, et al.
Publicado: (2019) -
Epidermal Growth Factor Receptor: A Potential Therapeutic Target for Diabetic Kidney Disease
por: Sheng, Lili, et al.
Publicado: (2021) -
PG F(2α) Receptor: A Promising Therapeutic Target for Cardiovascular Disease
por: Zhang, Jian, et al.
Publicado: (2010) -
Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer
por: Sudhesh Dev, Sareshma, et al.
Publicado: (2021) -
Probiotics and Vitamin D/Vitamin D Receptor Pathway Interaction: Potential Therapeutic Implications in Inflammatory Bowel Disease
por: Pagnini, Cristiano, et al.
Publicado: (2021)